Positive interim findings on new once-weekly HIV treatment pill
|
... antiretroviral formulation appears to be as
effective as the daily pills. The new pill contains only two antiretrovirals,
islatravir and lenacapavir. |
BioNTech Launches mRNA HIV Vaccine Trial
... antiretroviral therapy for at least 12 months will receive four injections. Enrollment will span participants aged 18 to 50 years; those with HIV ... View article...